2026-2034年全球结构性心臟病器材市场规模、份额、趋势和成长分析报告

预计结构性心臟器材市场将从 2025 年的 228.2 亿美元成长到 2034 年的 422.3 亿美元，2026 年至 2034 年的复合年增长率为 7.08%。

由于心臟瓣膜疾病病例不断增加，全球结构性心臟植入器材市场正经历强劲成长。这些器械用于治疗结构性缺陷，无需进行开胸手术。微创手术日益普及也推动了市场扩张。

人口老化和医疗技术的进步是成长要素。诊断影像系统和设备设计的改进带来了更好的治疗效果。人们对早期诊断意识的提高以及心臟护理设施的扩建也促进了成长。

由于创新经导管器械的研发，预计未来市场将持续成长。新兴市场医疗保健服务的普及将创造新的机会，而器械的高成本和监管要求可能会限制其广泛应用。总体而言，人们对心血管健康的日益关注将推动长期需求。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球结构性心臟病器材市场：依产品划分

• 市场分析、洞察与预测
• 生物瓣膜/组织瓣膜
• 机械心臟瓣膜
• 环状成形术环
• 闭合装置
• 配件

第五章：全球结构性心臟病器材市场：依手术类型划分

• 市场分析、洞察与预测
• 替代治疗
• 修復治疗

第六章：全球结构性心臟病器材市场：依适应症划分

• 市场分析、洞察与预测
• 瓣膜狭窄
• 瓣膜逆流
• 心肌病
• 先天性心臟疾病
• 其他的

第七章：全球结构性心臟病器材市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • LivaNova Plc
  • Lepu Medical
  • Micro Interventional Devices Inc
  • LifeTech Scientific Corporation
  • Cryolife Inc

The Structural Heart Devices Market size is expected to reach USD 42.23 Billion in 2034 from USD 22.82 Billion (2025) growing at a CAGR of 7.08% during 2026-2034.

The global structural heart devices market has experienced strong growth due to rising cases of heart valve disorders. These devices are used to treat structural defects without open-heart surgery. Increasing preference for minimally invasive procedures has supported market expansion.

Major drivers include aging populations and advancements in medical technology. Improved imaging systems and device designs have enhanced treatment outcomes. Growing awareness about early diagnosis and expanding cardiac care facilities also contribute to growth.

In the future, the market is expected to grow with the development of innovative transcatheter devices. Expanding healthcare access in emerging markets will create opportunities. However, high device costs and regulatory requirements may limit adoption. Overall, rising focus on heart health will drive long-term demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Biological/Tissue Valves
• Mechanical Heart Valves
• Annuloplasty Rings
• Occluders
• Accessories

By Procedure

• Replacement Procedures
• Repair Procedures

By Indication

• Valve Stenosis
• Valve Regurgitation
• Cardiomyopathy
• Congenital Heart Defects
• Others

COMPANIES PROFILED

• Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices Inc, LifeTech Scientific Corporation, Cryolife Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Biological/Tissue Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Mechanical Heart Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Annuloplasty Rings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Occluders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Replacement Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Repair Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Valve Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Valve Regurgitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiomyopathy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Congenital Heart Defects Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Procedure
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Procedure
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Procedure
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Procedure
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Procedure
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL STRUCTURAL HEART DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Abbott
  • 9.2.3 Boston Scientific Corporation
  • 9.2.4 Edwards Lifesciences Corporation
  • 9.2.5 LivaNova Plc
  • 9.2.6 Lepu Medical
  • 9.2.7 Micro Interventional Devices Inc
  • 9.2.8 LifeTech Scientific Corporation
  • 9.2.9 Cryolife Inc